**Abstract**

We have recently demonstrated that induction of sigma 1 receptor (Sig-1R) expression is caused by endoplasmic reticulum (ER) stress through the PERK pathway, which is one of the cell's responses to ER stress. In addition, it has been demonstrated that cell death signal transmission can be suppressed by up-regulation of Sig-1R. Fluvoxamine (Flv) is a selective serotonin re-uptake inhibitor (SSRI) that it is known to have a high affinity for Sig-1R. In the present study, we have shown that treatment of neuroblastoma cells with Flv induces Sig-1R by directly increasing ATF4 translational regulation without any involvement of PERK pathway. The Flv-mediated induction of Sig-1R prevents neuronal cell death by ER stress. Moreover the ER stress resistance by Flv results in reduction of infarction area due to focal cerebral ischemia in mice. This study shows that Flv, frequently used in clinical practice, has the property of alleviating ER stress suggesting that it can be used as a feasible therapy for cerebral diseases caused by ER stress.
